Skip to main content
Premium Trial:

Request an Annual Quote

BD Files for FDA Approval of HPV Assay

NEW YORK (GenomeWeb) – Becton Dickinson announced today that it has submitted a pre-market approval application with the US Food and Drug Administration for its Onclarity HPV assay for human papillomavirus.

The submission is based on data collected during a two-year prospective study of more than 33,000 women, according to BD. It seeks approval to use the assay — which is designed to run on the BD Viper LT RT-PCR system — with BD SurePath specimens for the detection of 14 high-risk HPV types to determine the need for colposcopy for women 21 years and older with abnormal pap test results.

BD is also seeking approval for use of the test in women 30 years and older in conjunction with cervical cytology to adjunctively screen for high-risk HPV and individually identify virus subtypes 16, 18, and 45, as well as its use as a first-line primary cervical cancer screening test in women 25 years and old.

BD said that it intends to later seek FDA approval for the Onclarity HPV assay using genotyping beyond subtypes 16, 18, and 45.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.